FRANKFORT, Ky. (AP) — Tapping into his state's love of college basketball, Kentucky Attorney General Russell Coleman has ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an ...

Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...

A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug ... "best-in-class potential" for the drug, which Sanofi licensed from ...

A small business owner in San Francisco discovered this week that his brand’s logo and address may be linked to a drug-selling operation. Jamie Alexander, co-owner of Park Life, a gallery and gift ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

The White House has thrown its weight behind Musk, the highest-profile member of Trump's administration and a key donor to ...

In the Fall 2022 semester, Fordham undergraduates in the Logos Branding Art course taught by Professor Abby Goldstein, engaged in research and development of a logo that would be used on materials for ...

This month marks the fifth anniversary of the pandemic. We asked students how their lives are different today because of it. By The Learning Network President Trump abruptly stopped providing ...